Авторы

  • Djurabayeva M.X.
  • Allamuratova D.A.

Ключевые слова:

MDR-TB (multi-drug resistant tuberculosis), sil kasalligi, geterorezistentlik, dori vositalariga chidamlilik, Oxford Nanopore, Illumina, yangi avlod maqsadli sekvensiyalash (tNGS), diagnostik texnologiyalarni joriy etish, resurslari cheklangan mamlakatlar.

Библиографические ссылки

1. Zhdanova S., Heysell S. K., Ogarkov O., et al. Genomic epidemiology and drug resistance molecular markers of Mycobacterium tuberculosis in the Irkutsk region, Russia, and neighboring countries of the CIS // Infection, Genetics and Evolution. – 2024. – Vol. 118. – Article 105552.

2. Kozhamkulov U., Akhmetova G., Ismailov B., Tuleuova A. Multidrug resistant tuberculosis in Central Asia: epidemiology, diagnostic and treatment challenges in Uzbekistan and neighbouring countries // Antibiotics. – 2025. – Vol. 14(7). – P. 673.

3. Kayukova S. I., Vasilyeva I. A., Sterlikov S. A., et al. Tuberculosis in the post-pandemic period: epidemiological trends and challenges for the health systems of the CIS countries // Public Health and Healthcare. – 2025. – Vol. 12(1). – P. 14–29.

4. Skrahina A., Hurevich H., Zalutskaya A., et al. Drug-resistant tuberculosis in Eastern Europe and Central Asia // International Journal of Tuberculosis and Lung Disease. – 2019. – Vol. 23(10). – P. 1083–1091.

5. Skrahina A., Hurevich H., Zalutskaya A., et al. Treatment outcomes for drug-susceptible and multidrug-resistant tuberculosis in Uzbekistan // International Journal of Tuberculosis and Lung Disease. – 2022. – Vol. 26(6). – P. 545–554.

6. Mokrousov I., Vyazovaya A., Sinkov V., et al. Evolution and global spread of the Mycobacterium tuberculosis Beijing lineage: focus on the Commonwealth of Independent States (CIS) // Emerging Microbes & Infections. – 2024. – Vol. 13(1). – Article 2304512.

7. Kadura S., et al. Genomic surveillance of Mycobacterium tuberculosis resistance to new and repurposed drugs // The Lancet Microbe. – 2024. – Vol. 5(3). – P. e241–e252.

8. Nikolayevskyy V., Ismail N., Holme A., et al. Targeted next-generation sequencing for drug-resistant tuberculosis: a multi-centre study // Journal of Clinical Microbiology. – 2021. – Vol. 59, № 1. – P. e01815-20.

9. Cabibbe A. M., et al. Nanopore-based targeted sequencing test for direct tuberculosis identification, genotyping, and detection of drug resistance mutations: a side-by-side comparison of targeted next-generation sequencing technologies // Journal of Clinical Microbiology. – 2024. – Vol. 62(10). – P. e00815-24.

10. Mardis E.R. DNA sequencing technologies: 2006–2016. Nature Protocols. – 2017. – Vol. 12(2). – P. 213–218. doi:10.1038/nprot.2016.182

11. CDC NGS Quality Initiative Work Group. The Next Generation Sequencing Quality Initiative: framework for implementing NGS in clinical and public health laboratories // Centers for Disease Control and Prevention (CDC). – 2024. – Vol. 1. – P. 1–42.

12. Operario D.J., et al. Heteroresistance in Mycobacterium tuberculosis: explanations, diagnosis, and clinical implications // Clinical Microbiology Reviews. – 2018. – Vol. 31, № 4. – P. e00038-18.

13. Chen Z., Lee H., Smith R., Gupta A. Decoding the WHO Global Tuberculosis Report 2024: epidemiology and implications for global public health // Zoonoses and Public Health. – 2025. – Vol. 72. – P. 45–58.

14. Coll F., McNerney R., Guerra-Assunção J.A., et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains // Nature Communications. – 2014. – Vol. 5. – P. 4812.

15. Cook V.J., Dheda K., Masur H., et al. Sensitive diagnosis of paucibacillary tuberculosis with targeted next-generation sequencing: a molecular diagnostic study // BMC Medicine. – 2025. – Vol. 23. – No. 128.

16. Mehaffy C., et al. Clinical impact of subclonal drug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis // The Lancet Microbe. – 2024. – Vol. 5, № 8. – P. e742–e753.

17. Papaventsis D., Casali N., Kontsevaya I., et al. Whole-genome sequencing versus targeted next-generation sequencing of Mycobacterium tuberculosis: an individual isolate and sample-level diagnostic meta-analysis // The Lancet Infectious Diseases. – 2021. – Vol. 21, № 10. – P. 1445–1455.

18. de Araujo L., Tang Y.-W., Denkinger C., et al. Implementation of targeted next-generation sequencing for the diagnosis of drug-resistant tuberculosis in low-resource settings // Frontiers in Public Health. – 2023. – Vol. 11. – Article 1204064.

19. de Nooy A.E., Shrestha S., Addae A., et al. Cost-effectiveness of targeted next-generation sequencing for tuberculosis drug-resistance testing // Clinical Infectious Diseases. – 2026. – Vol. 82(1). – P. e119–e128.

20. Nguyen T. N. A., Anton Le Berre V., Bañuls A. L., Nguyen T. V. A. Molecular Diagnosis of Drug Resistant Tuberculosis: A Literature Review // Frontiers in Microbiology. – 2019. – Vol. 10. – Article 794.

21. Ismail N., Nimmo C., Allix-Béguec C., et al. Diagnostic accuracy of targeted next-generation sequencing for the detection of drug-resistant tuberculosis: a multicentre, retrospective study // The Lancet Microbe. – 2023. – Vol. 4(12). – P. e1001–e1011.

22. Farnia P., Velayati A.A., Ghanavi J., Farnia P. Tuberculosis: An Ongoing Global Threat // Advances in Experimental Medicine and Biology. – 2026. – Vol. 1484. – P. 1–31.

23. Ghajavand P.V., Varghese D., Ismail S., et al. Application of next-generation sequencing for diagnosis and clinical management of drug-resistant tuberculosis // Frontiers in Microbiology. – 2022. – Vol. 13. – Article 775030.

24. Goodwin S., McPherson J.D., McCombie W.R. Coming of age: ten years of next-generation sequencing technologies // Nature Reviews Genetics. – 2016. – Vol. 17(6). – P. 333–351.

25. Jung S. Targeted Next-Generation Sequencing in Drug-Resistant Tuberculosis: WHO Guidance and Practical Implementation Priorities // Biomedicines. – 2026. – Vol. 14(1). – P. 93.

26. Shrestha S., Addae A., Miller C., Ismail N., Zwerling A. Cost effectiveness of targeted next generation sequencing (tNGS) for detection of tuberculosis drug resistance in India, South Africa and Georgia: a modeling analysis // eClinicalMedicine. – 2024. – Vol. 79. – P. 103003.

27. Klepac-Ceraj V., Smits S.A., Owens S.M., et al. Understanding and overcoming the pitfalls and biases of next-generation sequencing methods // European Journal of Clinical Microbiology & Infectious Diseases. – 2019. – Vol. 38(9). – P. 1583–1593.

28. Chen Y., et al. Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China // Journal of Clinical Microbiology. – 2025. – Vol. 63, № 4. – P. e01813-24.

29. Mboowa G. Reimagining tuberculosis control in the era of genomics // Pathogens. – 2025. – Vol. 14(10):975.